Patents by Inventor Jonathan Gary
Jonathan Gary has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11932979Abstract: A laundry treating appliance for treating laundry items according to an automatic cycle of operation can include a cabinet defining an interior and having an access opening providing access to the interior. A tub can be located within the interior and can at least partially define a liquid chamber. A drum is rotatably mounted within the liquid chamber and at least partially defines a treating chamber. A clothes mover is located within the treating chamber and rotatable about a vertical axis. The clothes mover can include a base and a barrel.Type: GrantFiled: September 2, 2020Date of Patent: March 19, 2024Assignee: WHIRLPOOL CORPORATIONInventors: Jonathan A. Andrejczuk, Adam Gary, Philip J. Czarnecki, Benjamin D. Lowell, Sayer J. Murphy, James Jeffery, Eric W. Merrow, Emmanuel F. Gonzaga, Thomas R. Scott, Donald E. Erickson, Bradley D. Morrow, Jason S. Burnette, Kevin Peralta, Corinne M. Gorenchan, Kenneth L. McConnell
-
Publication number: 20240076374Abstract: The invention relates generally to antibodies that bind CD166, activatable antibodies that specifically bind to CD166 and methods of making and using these anti-CD166 antibodies and anti-CD166 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.Type: ApplicationFiled: July 18, 2023Publication date: March 7, 2024Inventors: James William WEST, Jason Gary SAGERT, Jonathan Alexander TERRETT, Annie Yang WEAVER, Luc Roland DESNOYERS, Shweta SINGH
-
Publication number: 20240003874Abstract: The present invention relates to compositions and methods use in designing immunoassay controls. In various aspects, the invention provides synthetic peptides comprising the sequence CPRRPYIL (SEQ ID NO: 1) or an analog thereof; ELAGLGFAELQC (SEQ ID NO: 4) or an analog thereof; and CDWRKNIDAL (SEQ ID NO: 8) or an analog thereof; specific binding reagents that bind to a CPRRPYIL (SEQ ID NO: 1), ELAGLGFAELQC (SEQ ID NO: 4) or CDWRKNIDAL (SEQ ID NO: 8) peptide; methods of producing such reagents; and assays utilizing such reagents to provide assay controls signals that are unrelated to the measurement of the analyte or analytes of interest in that no reagents used in the analyte assay(s) contribute to the control signal.Type: ApplicationFiled: June 23, 2023Publication date: January 4, 2024Inventors: Jonathan GARY, Scott RONGEY, James POWELL
-
Patent number: 11726085Abstract: The present invention relates to compositions and methods use in designing immunoassay controls. In various aspects, the invention provides synthetic peptides comprising the sequence CPRRPYIL (SEQ ID NO: 1) or an analog thereof; ELAGLGFAELQC (SEQ ID NO: 4) or an analog thereof; and CDWRKNIDAL (SEQ ID NO: 8) or an analog thereof; specific binding reagents that bind to a CPRRPYIL (SEQ ID NO: 1), ELAGLGFAELQC (SEQ ID NO: 4) or CDWRKNIDAL (SEQ ID NO: 8) peptide; methods of producing such reagents; and assays utilizing such reagents to provide assay controls signals that are unrelated to the measurement of the analyte or analytes of interest in that no reagents used in the analyte assay(s) contribute to the control signal.Type: GrantFiled: December 13, 2021Date of Patent: August 15, 2023Assignee: Quidel Cardiovascular Inc.Inventors: Jonathan Gary, Scott Rongey, James Powell
-
Publication number: 20220107314Abstract: The present invention relates to compositions and methods use in designing immunoassay controls. In various aspects, the invention provides synthetic peptides comprising the sequence CPRRPYIL (SEQ ID NO: 1) or an analog thereof; ELAGLGFAELQC (SEQ ID NO: 4) or an analog thereof; and CDWRKNIDAL (SEQ ID NO: 8) or an analog thereof; specific binding reagents that bind to a CPRRPYIL (SEQ ID NO: 1), ELAGLGFAELQC (SEQ ID NO: 4) or CDWRKNIDAL (SEQ ID NO: 8) peptide; methods of producing such reagents; and assays utilizing such reagents to provide assay controls signals that are unrelated to the measurement of the analyte or analytes of interest in that no reagents used in the analyte assay(s) contribute to the control signal.Type: ApplicationFiled: December 13, 2021Publication date: April 7, 2022Inventors: Jonathan GARY, Scott RONGEY, James POWELL
-
Patent number: 11237163Abstract: The present invention relates to compositions and methods use in designing immunoassay controls. In various aspects, the invention provides synthetic peptides comprising the sequence CPRRPYIL or an analog thereof; ELAGLGFAELQC or an analog thereof; and CDWRKNIDAL or an analog thereof; specific binding reagents that bind to a CPRRPYIL, ELAGLGFAELQC or CDWRKNIDAL peptide; methods of producing such reagents; and assays utilizing such reagents to provide assay controls signals that are unrelated to the measurement of the analyte or analytes of interest in that no reagents used in the analyte assay(s) contribute to the control signal.Type: GrantFiled: March 7, 2017Date of Patent: February 1, 2022Assignee: Quidel Cardiovascular Inc.Inventors: Jonathan Gary, Scott Rongey, James Powell
-
Publication number: 20190339264Abstract: The present invention relates to compositions and methods use in designing immunoassay controls. In various aspects, the invention provides synthetic peptides comprising the sequence CPRRPYIL or an analog thereof; ELAGLGFAELQC or an analog thereof; and CDWRKNIDAL or an analog thereof; specific binding reagents that bind to a CPRRPYIL, ELAGLGFAELQC or CDWRKNIDAL peptide; methods of producing such reagents; and assays utilizing such reagents to provide assay controls signals that are unrelated to the measurement of the analyte or analytes of interest in that no reagents used in the analyte assay(s) contribute to the control signal.Type: ApplicationFiled: March 7, 2017Publication date: November 7, 2019Inventors: Jonathan GARY, Scott RONGEY, James POWELL
-
Publication number: 20140315734Abstract: The invention encompasses diagnosis and prognosis in the context of heart or renal failure, particularly in subjects who exhibit a normal body fluid level of a natriuretic peptide. The invention also relates to methods of assigning an increased likelihood that a subject having AKI is susceptible to AKI progression. The invention relates in part to assigning a diagnosis of heart and/or renal failure, and/or an outcome risk (e.g., worsening cardiac and/or renal function or a mortality risk) to a subject based, at least in part, on the result(s) obtained from an assay that detects WAP four-disulfide core domain protein 2 performed on a body fluid sample obtained from a subject.Type: ApplicationFiled: July 3, 2012Publication date: October 23, 2014Applicant: ALERE SAN DIEGO INC.Inventors: William D. Arnold, Christelle Jost, Brian Noland, Jonathan Gary, Joseph Buechler, Vance Wong, Scott Harold Rongey, Uday Kumar Veeramallu, Kelline Marie Rodems
-
Patent number: 8795975Abstract: The present invention relates in part to diagnosing the occurrence of heart failure, particularly in subjects who exhibit a normal body fluid level of a natriuretic peptide. The present invention further relates in part to assigning an outcome risk (e.g., worsening cardiac function or a mortality risk, a risk of rehospitalization) to a subject. The methods comprise performing one or more assays that detect one or more biomarkers selected from the group consisting of WAP4C, ESAM, LTBR, Mesothelin, and Syndecan-1 performed on a body fluid sample obtained from a subject, and assigning diagnosis or risk based, at least in part, on the result(s) obtained thereby.Type: GrantFiled: November 25, 2011Date of Patent: August 5, 2014Assignee: Alere San Diego, Inc.Inventors: William D. Arnold, Christelle Jost, Brian Noland, Jonathan Gary, Joseph Buechler, Vance Wong, Scott Harold Rongey, Uday Kumar Veeramallu, Kelline Marie Rodems
-
Publication number: 20140147867Abstract: The present invention relates in part to diagnosing the occurrence of heart failure, particularly in subjects who exhibit a normal body fluid level of a natriuretic peptide. The present invention further relates in part to assigning an outcome risk (e.g., worsening cardiac function or a mortality risk, a risk of rehospitalization) to a subject. The methods comprise performing one or more assays that detect one or more biomarkers selected from the group consisting of WAP4C, ESAM, LTBR, Mesothelin, and Syndecan-1 performed on a body fluid sample obtained from a subject, and assigning diagnosis or risk based, at least in part, on the result(s) obtained thereby.Type: ApplicationFiled: November 25, 2011Publication date: May 29, 2014Applicant: ALERE SAN DIEGO, INC.Inventors: William D. Arnold, Christelle Jost, Brian Noland, Jonathan Gary, Joseph Buechler, Vance Wong, Scott Harold Rongey, Uday Kumar Veeramallu, Kelline Marie Rodems
-
Publication number: 20030184650Abstract: A method of transferring a plurality of digital images captured by a digital camera to a computer and for processing such digital images includes using the digital camera to capture a plurality of digital images of one or more scenes; transferring such captured digital images to the computer wherein they are stored in a memory; and continuing the capture and transfer of digital images to the memory while simultaneously processing other digital images stored in the memory which were previously captured by the cam era wherein such processing produces digital images which are suitable for subsequent use.Type: ApplicationFiled: March 27, 2002Publication date: October 2, 2003Applicant: Eastman Kodak CompanyInventors: Robert W. Brown, James Doran, Jonathan Gary, Mark A. Prescott, James R. Jarrett
-
Publication number: 20010013052Abstract: A system and method for disparate systems to communicate with each other, including a nodal network for distributed processing and caching. The nodal network includes at least one node. The at least one node is coupleable to an Internet. A main server is coupled to the Internet. An application and a database each coupled to the main server. Each node comprises a network server, a Distributed Working Environment for Application Processing (DWEAP) for execution of a runnable module (RUM) of the application, an application module cache for caching the RUM, and a synchronized database cache for caching a portion of the database. The portion of database is required for execution of the application.Type: ApplicationFiled: March 29, 2001Publication date: August 9, 2001Inventors: Yobie Benjamin, Greg Hoglund, Abhideep Singh, Jonathan Gary